Ticker brief · 2026-08-16
TXG 10X GENOMICS INC-CLASS A
Guidance raise reinforces momentum, though profit-taking risk is rising
Consumer, Non-cyclical · Healthcare-Products
Lean: bullishlast close
$61.54
1 day
-5.1%
14 days
+9.7%
mkt cap
$5.0B
signals 14d
30
authors 14d
20
crowd 14d
-1.5σ
TXG sentiment is bullish, supported by raised full-year guidance and broad momentum evidence, but several prominent advocates have recently had negative trading alpha. The guidance raise was the most important late-week fundamental development. A 13-of-14-week advance, doubling screens, bullish options activity, and an explicit trim call imply a crowded momentum trade vulnerable to consolidation.
BULL CAMP
Bulls argue that raised full-year guidance validates the rally while persistent relative strength, 52-week highs, and bullish options activity support further upside. Genomics and biotech exposure is also attracting renewed interest.
Key voices“TXG advanced after management raised full-year guidance.”— @Hedgeye · tweet ↗
BEAR / SKEPTIC
—
Hypotheses5direction · basis · magnitude · supporters — NEW = first seen this week
▲TXG raising full-year guidance provides fresh business validation and supports a continued positive market reappraisal.
@HedgeyeHIGHB-2.551s · insight
▲Persistent gains, 52-week highs, and repeated doubling screens indicate TXG remains in a powerful technical uptrend.
@KeithMcCulloughHIGHA+0.952s · insight@NirAoo7MEDIUMC-1.183s@NickDrendelMEDIUMC-1.091s@TedHZhangHIGHB+0.571s · insight@fundmyfundMEDIUMB-1.581s · insight
▲Unusual bullish options volume indicates speculative positioning for additional TXG upside after the recent advance.
@OptionsFlowBossLOW-MEDIUMC1s
▲Renewed investor appetite for biotech and genomics makes TXG an attractive vehicle for sector exposure.
@IncomeSharksMEDIUM-HIGHB-0.251s · insight
◆TXG should be trimmed into further strength because the extended move risks forming a right-shoulder pullback.
@MarketMaestro1MEDIUM-HIGHC-2.461s
Direct calls1authors taking explicit directional positions
@MarketMaestro1MEDIUM-HIGHC-2.46
Take profits if TXG extends into the referenced higher range because a right-shoulder pullback may follow.
News / data points5discrete events + data quoted by authors
@HedgeyeHIGHB-2.55
TXG rose after raising full-year guidance.
@KeithMcCulloughHIGHA+0.95
TXG gained 14% as bearish hedge-fund positioning was challenged.
@fundmyfundMEDIUMB-1.58
TXG advanced during 13 of the last 14 weeks.
@NirAoo7MEDIUMC-1.18
TXG appeared among liquid stocks that doubled over the last 65 days.
@NickDrendelMEDIUMC-1.09
TXG screened among liquid 52-week-high stocks that doubled over the past year.
Desk readconvergence assessment
The discussion is strongly converged on bullish price momentum, with no substantive bearish thesis; disagreement centers on whether to chase or harvest gains after the extension. Credibility is superficially strong, but key bulls Hedgeye, KeithMcCullough, and OptionsHawk have trader_score_20 readings of -2.1, -1.54, and -1.41, respectively, weakening the smart-money signal. Continued guidance-backed execution would sustain the view, while failure to hold the breakout after a 13-of-14-week run would validate the trim thesis.
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 76% mid · 22 pctile own 1y | IV/HV 1.06× (as of 2026-08-26) |
| Skew — 25Δ RR 30d | -0.047 53 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +0.44 elevated | 5-session Δ -0.02 (as of 2026-07-08) |
| OI alarm | quiet | last alarm 2026-06-05 (z=3.9) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-15 → 2026-08-28 · now +0.35 (−1 bearish … +1 bullish)
Who spoke20
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PrimeTrading_ | C | -4.67 | 4 | +0.18 |
| @NirAoo7 | C | -1.18 | 3 | +0.20 |
| @TheNewMoney_app | C | · | 3 | +0.25 |
| @IncomeSharks | B | -0.25 | 2 | +0.53 |
| @JaguarAnalytics | B | +0.35 | 2 | -0.08 |
| @SteveDJacobs | C | -1.22 | 2 | +0.35 |
| @Sam_Badawi | C | -1.46 | 1 | -0.30 |
| @enrichtrades | C | -0.62 | 1 | +0.82 |
| @davevermilion | A | -2.22 | 1 | +0.20 |
| @Benzinga | C | +0.89 | 1 | -0.30 |
| @bullishchart | C | -2.31 | 1 | +0.15 |
| @Tickeron | C | +0.16 | 1 | +0.20 |
| @PolycarpFX | B | +1.12 | 1 | +0.00 |
| @NickDrendel | C | -1.09 | 1 | +0.20 |
| @DGretta_Author | C | -0.32 | 1 | +0.50 |
| @Nice_Stock_ | C | -1.23 | 1 | +0.20 |
| @StockMKTNewz | C | +0.59 | 1 | +0.25 |
| @artinmemes | C | -0.67 | 1 | +0.45 |
| @VladBastion | B | -1.80 | 1 | +0.35 |
| @StonkValue | C | -1.74 | 1 | +0.35 |
Recent signals30of 30 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @StonkValue | +0.35 | Includes TXG as a genomics play and cites Q2 revenue of $151M. | — | tweet ↗ |
| 2026-08-27 | @PrimeTrading_ | +0.10 | Lists liquid leaders ranked by relative strength. | -5.1% | tweet ↗ |
| 2026-08-27 | @VladBastion | +0.35 | Ranks beaten-down stocks by momentum scores and identifies signs of reversal. | -5.1% | tweet ↗ |
| 2026-08-26 | @PrimeTrading_ | +0.20 | Relative-strength scan of liquid market leaders. | -4.2% | tweet ↗ |
| 2026-08-26 | @artinmemes | +0.45 | Presents a bullish AI-healthcare rotation thesis and a timing-oriented stock basket. | -4.2% | tweet ↗ |
| 2026-08-25 | @PrimeTrading_ | +0.25 | Relative-strength scan lists liquid market leaders in ranked order. | -4.9% | tweet ↗ |
| 2026-08-25 | @StockMKTNewz | +0.25 | Lists stocks that reached new 52-week highs; output capped at six tickers. | -4.9% | tweet ↗ |
| 2026-08-25 | @NirAoo7 | +0.25 | Lists additional names appearing in crypto and biotech/genomics scans. | -4.9% | tweet ↗ |
| 2026-08-24 | @PrimeTrading_ | +0.15 | Relative-strength scan lists leading liquid stocks without entry intent. | -3.5% | tweet ↗ |
| 2026-08-24 | @Nice_Stock_ | +0.20 | Lists ARKG's leading portfolio weights and calls its holdings currently popular. | -3.5% | tweet ↗ |
| 2026-08-23 | @DGretta_Author | +0.50 | Reports TXG as up 300% year to date and frames it as a highly successful holding. | -5.5% | tweet ↗ |
| 2026-08-22 | @NickDrendel | +0.20 | Screens liquid stocks at 52-week highs that doubled over the past year, sorted by volume. | -5.5% | tweet ↗ |
| 2026-08-22 | @SteveDJacobs | +0.35 | Argues swing-entry windows, leadership, fundamentals, and risk controls matter more than exact timing. | -5.5% | tweet ↗ |
| 2026-08-22 | @SteveDJacobs | +0.35 | Argues swing-entry windows, leadership, fundamentals, and risk controls matter more than exact timing. | -5.5% | tweet ↗ |
| 2026-08-21 | @TheNewMoney_app | +0.25 | Reports $97,664 of TXG 90 calls purchased for the February 2027 expiry. | -5.5% | tweet ↗ |
| 2026-08-21 | @TheNewMoney_app | +0.25 | Reports $97,776 of TXG 90 calls purchased for the February 2027 expiry. | -5.5% | tweet ↗ |
| 2026-08-21 | @TheNewMoney_app | +0.25 | Reports $96,030 of TXG 90 calls purchased for the February 2027 expiry. | -5.5% | tweet ↗ |
| 2026-08-21 | @JaguarAnalytics | -0.50 | Mocking reference to TXG and its chart conveys a negative retrospective view. | -5.5% | tweet ↗ |
| 2026-08-21 | @JaguarAnalytics | +0.35 | Ironically praises precision-medicine names while criticizing excessive attention to Bitcoin. | -5.5% | tweet ↗ |
| 2026-08-21 | @PolycarpFX | +0.00 | Flags a leading volume print but asks whether ARKG will rise or fall | -5.5% | tweet ↗ |
| 2026-08-21 | @Tickeron | +0.20 | Reports TXG gaining 35.7% over 30 days. | -5.5% | tweet ↗ |
| 2026-08-20 | @bullishchart | +0.15 | Quantifies TXG's record nine-week, 94.5% advance while warning one observation is not an edge. | -3.6% | tweet ↗ |
| 2026-08-20 | @IncomeSharks | +0.50 | Attributes sharp gains in Tempus AI and 10x Genomics to a referenced health-related catalyst. | -3.6% | tweet ↗ |
| 2026-08-20 | @Benzinga | -0.30 | Ark bought AVGO, CBRS and NET while selling AMD, RBLX and TXG across its funds. | -3.6% | tweet ↗ |
| 2026-08-20 | @davevermilion | +0.20 | Notes TXG has been highlighted for the past year, implying a favorable stance. | -3.6% | tweet ↗ |
| 2026-08-19 | @enrichtrades | +0.82 | Frames genomics as a strengthening theme led by TXG and identifies continuation names. | -1.0% | tweet ↗ |
| 2026-08-19 | @Sam_Badawi | -0.30 | Quantifies ARK ETF purchases and sales across six directly named holdings. | -1.0% | tweet ↗ |
| 2026-08-19 | @NirAoo7 | +0.15 | Screen lists liquid Stage 2/2A stocks up over 4% with daily closing ranges above 80%. | -1.0% | tweet ↗ |
| 2026-08-19 | @IncomeSharks | +0.55 | Highlights TXG posting ten consecutive green weeks. | -1.0% | tweet ↗ |
| 2026-08-15 | @NirAoo7 | +0.20 | Lists liquid stocks that doubled over the last 65 days. | +9.7% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.